Welcome to the Virtual MS Center!
Ask any question you want about Multiple Sclerosis and one of our experts will answer it as soon as possible.
There is no reason to believe they could not be used together. Further studies will be needed to determine if VLA-4 blockade by the monoclonal antibody Tysabri interferes with the ability of an anti-Lingo antibody reaching it’s target in the nervous system.
Rip Kinkel MD
Comments are closed.
PLEASE NOTE: This information/opinions on this site should be used as an information source only. This information does not create any patient-HCP relationship, and should not be used as a substitute for professional diagnosis and treatment. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition.